Patents by Inventor Vikram Bhogadi

Vikram Bhogadi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted benzimidazolone compounds
    Patent number: 12187723
    Abstract: Disclosed are compounds of Formula (I) N-oxides, or salts thereof, wherein G, A, R1, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
    Type: Grant
    Filed: May 7, 2020
    Date of Patent: January 7, 2025
    Assignee: Bristol-Myers Squibb Company
    Inventors: Alaric J. Dyckman, Laxman Pasunoori, Sreekantha Ratna Kumar, Srinivasan Kunchithapatham Duraisamy, Pitani Veera Venkata Srinivas, Vikram Bhogadi, Subramanya Hegde
  • SUBSTITUTED PYRAZOLE COMPOUNDS AS TOLL RECEPTOR INHIBITORS
    Publication number: 20230117470
    Abstract: Disclosed are compounds of Formula (I) N-oxides, or salts thereof, wherein G, A, R1, and R5 are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
    Type: Application
    Filed: October 30, 2020
    Publication date: April 20, 2023
    Inventors: Laxman Pasunoori, Sreekantha Ratna Kumar, Pitani Veera Venkata Srinivas, Vikram Bhogadi, Duraisamy Kunchithapatham Srinivasan, Anupama Kandhi Ramachandra Reddy, Rushith Kumar Anumula, Alaric J. Dyckman
  • SUBSTITUTED BENZIMIDAZOLONE COMPOUNDS
    Publication number: 20220289739
    Abstract: Disclosed are compounds of Formula (I) N-oxides, or salts thereof, wherein G, A, R1, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
    Type: Application
    Filed: May 7, 2020
    Publication date: September 15, 2022
    Inventors: Alaric J. DYCKMAN, Laxman Pasunoori, Sreekantha Ratna Kumar, Srinivasan Kunchithaptham Duraisamy, Pitani Veera Venkata Srinivas, Vikram Bhogadi, Subramanya Hegde